IL28B polymorphisms associated with therapy response in Chilean chronic hepatitis C patients

被引:1
作者
Mauricio Venegas [1 ]
Rodrigo A Villanueva [2 ]
Katherine González [1 ]
Javier Brahm [1 ]
机构
[1] Centro de Estudios Avanzados de las Hepatitis Virales,Sección de Gastroenterología,Departamento de Medicina,Hospital Clínico Universidad de Chile
[2] Centro de Estudios Avanzados de las Hepatitis Virales,Laboratorio de Virus Hepatitis,Programa de Virología,Instituto de Ciencias Biomédicas,Facultad de Medicina,Universidad de Chile
关键词
IL28B; Hepatitis C virus; Chile; Pegylated interferon; Ribavirin;
D O I
暂无
中图分类号
R512.63 [];
学科分类号
100401 ;
摘要
AIM:To analyze the association of three IL28B single nucleotide polymorphisms with response to therapy in Chilean patients infected with hepatitis C virus CV.METHODS:We studied two groups of patients with chronic CV infection genotype 1,under standard combined treatment with pegylated interferon plus ribavirin.One group consisted of 50 patients with sustained virological response,whereas the second group consisted of 49 null responders.In order to analyze the IL28B single nucleotide polymorphisms rs12979860,rs12980275 and rs8099917,samples were used for polymerase chain reaction amplification,and the genotyping was performed by restriction fragment lengthpolymorphism.RESULTS:The IL28B rs12979860 CC,rs12980275 AA and rs8099917 TT genotypes were much more frequently found in patients with sustained virological response compared to null responders 38%,44% and 50% vs 2%,8.2% and 8.2%,respectively.These differences were highly significant in all three cases(P < 0.0001.CONCLUSION:The three IL28B polymorphisms studied are strongly associated with sustained virological response to therapy in Chilean patients with chronic CV genotype 1.
引用
收藏
页码:3636 / 3639
页数:4
相关论文
共 50 条
  • [21] The Correlation of Il28B Genotype With Sustained Virologic Response In Romanian Patients With Chronic Hepatitis C
    Sporea, Ioan
    Popescu, Alina
    Curescu, Manuela
    Sirli, Roxana
    Dan, Isabel
    Goldis, Adrian
    Gradinaru, Oana
    Ardelean, Melania
    Danila, Mirela
    Bota, Simona
    Deleanu, Alexandra
    HEPATITIS MONTHLY, 2011, 11 (12) : 975 - 979
  • [22] IL28B Polymorphisms as a Pretreatment Predictor of Response to HCV Treatment
    Berger, Christoph T.
    Kim, Arthur Y.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2012, 26 (04) : 863 - +
  • [23] Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients
    Nakamoto, Shingo
    Kanda, Tatsuo
    Imazeki, Fumio
    Wu, Shuang
    Arai, Makoto
    Fujiwara, Keiichi
    Yokosuka, Osamu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2011, 46 (7-8) : 955 - 961
  • [24] The Association of Substitutions in the Hepatitis C Virus Subtype 1b Core Gene and IL28B Polymorphisms With the Response to Peg-IFNα-2a/RBV Combination Therapy in Azerbaijani Patients
    Bokharaei-Salim, Farah
    Salehi-Vaziri, Mostafa
    Sadeghi, Farzin
    Esghaei, Maryam
    Monavari, Seyed Hamidreza
    Alavian, Seyed Moayed
    Fakhim, Shahin
    Keyvani, Hossein
    HEPATITIS MONTHLY, 2016, 16 (05)
  • [25] Impact of IL28B polymorphisms on 24-week telaprevir-based combination therapy for Asian chronic hepatitis C patients with hepatitis C virus genotype 1b
    Tsubota, Akihito
    Shimada, Noritomo
    Atsukawa, Masanori
    Abe, Hiroshi
    Kato, Keizo
    Ika, Makiko
    Matsudaira, Hiroshi
    Nagatsuma, Keisuke
    Matsuura, Tomokazu
    Aizawa, Yoshio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (01) : 144 - 150
  • [26] Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C
    Staettermayer, Albert Friedrich
    Rutter, Karoline
    Beinhardt, Sandra
    Scherzer, Thomas-Matthias
    Stadlmayr, Andreas
    Hofer, Harald
    Wrba, Fritz
    Steindl-Munda, Petra
    Krebs, Michael
    Datz, Christian
    Trauner, Michael
    Ferenci, Peter
    JOURNAL OF HEPATOLOGY, 2012, 57 (03) : 492 - 498
  • [27] Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients
    Sarrazin, Christoph
    Susser, Simone
    Doehring, Alexandra
    Lange, Christian Markus
    Mueller, Tobias
    Schlecker, Christina
    Herrmann, Eva
    Loetsch, Joern
    Berg, Thomas
    JOURNAL OF HEPATOLOGY, 2011, 54 (03) : 415 - 421
  • [28] Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection
    Seto, W. -K.
    Tsang, O. T. -Y.
    Liu, K.
    Chan, J. M. -C.
    Wong, D. K. -H.
    Fung, J.
    Lai, C. -L.
    Yuen, M. -F.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (07) : 470 - 477
  • [29] Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy
    Lopez-Rodriguez, R.
    Hernandez-Bartolome, A.
    Borque, M. J.
    Rodriguez-Munoz, Y.
    Martin-Vilchez, S.
    Trapero-Marugan, M.
    Garcia-Buey, L.
    de Rueda, P. Munoz
    Rodrigo, L.
    Vidal-Castineira, J. R.
    Salmeron, J.
    Moreno-Otero, R.
    Sanz-Cameno, P.
    GENES AND IMMUNITY, 2013, 14 (05) : 317 - 324
  • [30] Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C
    Boglione, Lucio
    Cusato, Jessica
    Cariti, Giuseppe
    Di Perri, Giovanni
    D'Avolio, Antonio
    INFECTION GENETICS AND EVOLUTION, 2017, 53 : 195 - 198